NeuroSearch Shares Boosted By Tesofensine Obesity Data Sep. 19, 2007 By Cormac Sheridan Shares in NeuroSearch A/S gained almost 22 percent Monday on news that its candidate obesity drug tesofensine attained an average weight reduction of about 10 ten percent in a Phase IIb clinical trial. (BioWorld International)Read More
Ganymed Adds To Series C; Closes 37.2M Financing Round Sep. 19, 2007 By Cormac Sheridan No AbstractRead More
RSS